CES-2 (carboxylesterase-2) for evaluation of atrial fibrillation-related stroke

摘要

The present invention relates to a method for evaluating stroke risk of a subject, the method comprising determining the amount of CES-2 in a sample of the subject, and evaluating the risk of stroke by comparing the amount of CES-2 with a reference amount. do. In addition, the present invention relates to a method of evaluating the efficacy of an anticoagulant therapy and a method of identifying a subject suitable for administration of at least one anticoagulant drug or for increasing the dose of at least one anticoagulant drug.